Literature DB >> 3756821

Involvement of the central nervous system by ovarian carcinoma.

M Stein, M Steiner, B Klein, D Beck, J Atad, A Kuten, E Robinson, D Goldsher.   

Abstract

Ovarian carcinoma rarely metastasizes to the central nervous system (CNS). Of 110 patients with epithelial ovarian carcinoma treated at the Northern Israel Oncology Center between the years 1979 and 1985, only five (4.5%) had CNS involvement. The median age of the patients with 54.5 years. All of them had treatment with cisplatin and Adriamycin (doxorubicin). The median duration from diagnosis to the development of brain involvement was 17 months. The median survival time was 28 months from diagnosis of carcinoma and 2 months from diagnosis of CNS disease. The increased incidence of this kind of metastasis in patients achieving local control of their advanced disease suggests that a change in the pattern of metastatic spread or the prolonged survival permits occult CNS metastases to become apparent. A routine computerized axial tomography (CAT) scan of the brain should therefore be performed on patients with ovarian carcinoma with prolonged survival.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756821     DOI: 10.1002/1097-0142(19861101)58:9<2066::aid-cncr2820580917>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate.

Authors:  Yasushi Goto; Noriyuki Katsumata; Shunichi Nakai; Yuko Sasajima; Kan Yonemori; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Yasuhiro Fujiwara
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

Review 2.  Modern management of rare brain metastases in adults.

Authors:  Matthias J Krammer; Andre Tomasino; David B Schul; Sabrina T Astner; Michael P Meier; Christianto B Lumenta
Journal:  J Neurooncol       Date:  2011-06-21       Impact factor: 4.130

3.  Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases.

Authors:  Giancarlo D'Andrea; Raffaelino Roperto; Lavinia Dinia; Emanuela Caroli; Maurizio Salvati; Luigi Ferrante
Journal:  Neurosurg Rev       Date:  2004-11-19       Impact factor: 3.042

4.  Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.

Authors:  Laura M Divine; Nora T Kizer; Andrea R Hagemann; Meredith E Pittman; Ling Chen; Matthew A Powell; David G Mutch; Janet S Rader; Premal H Thaker
Journal:  Gynecol Oncol       Date:  2016-05-08       Impact factor: 5.482

5.  Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival.

Authors:  Sewit Teckie; Vicky Makker; Viviane Tabar; Kaled Alektiar; Carol Aghajanian; Martee Hensley; Kathryn Beal
Journal:  Radiat Oncol       Date:  2013-02-15       Impact factor: 3.481

6.  Brain metastases from ovarian carcinoma.

Authors:  Ettie Piura; Benjamin Piura
Journal:  ISRN Oncol       Date:  2011-12-01

7.  Stereotactic radiosurgery for brain metastasis from gynecological malignancies.

Authors:  Ekkehard Kasper; Franziska Ippen; Eric Wong; Eric Uhlmann; Scott Floyd; Anand Mahadevan
Journal:  Oncol Lett       Date:  2017-01-18       Impact factor: 2.967

8.  Prolonged Survival and Restored Useful Life by Early Induction of Intrathecal Chemotherapy in a Patient with Leptomeningeal Carcinomatosis from Ovarian Cancer.

Authors:  Kento Takahara; Makoto Katayama; Ryota Tamura
Journal:  Brain Sci       Date:  2022-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.